通过可扩展的数字干预来监测喘症状:一项随机临床试验
Robert S Rudin1, Savanna Plombon2, Jorge Sulca Flores2
1Health Care Division, RAND, Boston, Massachusetts.
JAMA network open
|April 23, 2025
概括
一个用于监测喘症状的移动健康应用程序改善了生活质量,但没有达到最小的重要变化. 低激活水平的患者可能会获得更大的好处.
科学领域:
- 肺部医学 肺部医学
- 数字健康数字健康
- 临床试验 临床试验
背景情况:
- 喘影响全球数百万人,症状监测显示了潜在的益处,但采用程度有限.
- 需要可扩展的干预措施来改善喘管理和患者的治疗结果.
研究的目的:
- 评估移动健康 (mHealth) 喘症状监测干预措施对喘相关生活质量和医疗保健利用的影响.
- 评估可扩展的数字健康工具在治疗喘症状方面的有效性.
主要方法:
- 一项随机临床试验,涉及7个初级保健诊所的366名成人喘患者.
- 干预组使用mHealth应用程序进行每周的症状跟踪,峰值流量监测和触发记录.
- 常规护理组接受了标准的喘指导;使用强大的线性回归来比较结果.
主要成果:
- 干预组显示迷你喘生活质量问卷 (MiniAQLQ) 得分在统计学上显著增加,但它没有达到最小重要的变化值.
- 探索性分析表明,包括年轻成年人,基线患者激活率低的患者和不受控制的喘在内的子组的MiniAQLQ得分得到了更大的改善.
- 干预组和通常护理组之间没有观察到与喘相关的医疗保健利用事件的显著差异.
结论:
- 一个可扩展的mHealth喘症状监测干预措施并没有在生活质量方面取得微不足道的改善.
- 这种干预可以为特定的患者子组带来好处,特别是那些基线激活水平较低的患者.
- 进一步的研究是有必要的,以优化数字健康干预措施,为不同的喘患者群体.
更多相关视频
10:45A Community-based Stress Management Program: Using Wearable Devices to Assess Whole Body Physiological Responses in Non-laboratory Settings
Published on: January 22, 2018
7.6K
15:00Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
Published on: February 3, 2023
2.4K
相关概念视频
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Inhaled Medications
197
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
197
